Compare Immunovant Inc. Common Stock (IMVT) vs Navitas Semiconductor Corporation Common Stock (NVTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Navitas Semiconductor Corporation Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Navitas Semiconductor Corporation Common Stock trades at $11.19 (market cap $2.97B). The key difference: Immunovant Inc. Common Stock is far larger — about 2.2× Navitas Semiconductor Corporation Common Stock's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Navitas Semiconductor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Navitas Semiconductor Corporation Common Stock for 0 Days on average.
| IMVT | NVTS | |
|---|---|---|
Market Cap | $6.62B | $2.97B |
Volume | 1,131,364 | 18,229,864 |
Sector | Health | Technology |
52-Week High | $44.96 | $31.79 |
52-Week Low | $17.03 | $7.14 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $2.41B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Navitas Semiconductor Corporation Common Stock
Navitas Semiconductor designs and markets gallium nitride and silicon carbide power semiconductors. Its products are used in power conversion and charging for data centers, energy infrastructure, and industrial applications.
Read more on NVTS →
